Fatal pneumonia caused by Burkholderia cepacia 9 months after resection of aspergilloma

Respirology

Volumn 8, Issue 3, 2003, Pages 401-403

  Ishizuka, Tamotsu ^a   Oyama, Tatsuya ^a   Sato, Minoru ^a   Hisada, Takeshi ^a   Takagi, Hitoshi ^a   Hamada, Tetsuya ^a   Kimura, Takao ^a   Kashiwabara, Kenji ^a   Mori, Masatomo ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Aspergilloma; Aspergillus fumigatus; Burkholderia cepacia; Pneumonia; Respiratory failure

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; CEFOZOPRAN; CEFTAZIDIME; CHLORAMPHENICOL DERIVATIVE; MEROPENEM; SPARFLOXACIN; TRIMETHOPRIM;

AGED; ANTIBIOTIC RESISTANCE; ARTICLE; ASPERGILLUS FUMIGATUS; BACTERIAL PNEUMONIA; BURKHOLDERIA CEPACIA; CASE REPORT; CHRONIC GRANULOMATOUS DISEASE; CYSTIC FIBROSIS; FUNGUS ISOLATION; HUMAN; IMMUNOCOMPETENCE; LUNG ASPERGILLOSIS; LUNG PARENCHYMA; LUNG RESECTION; MALE; PLEURA CAVITY; PRIORITY JOURNAL; RESPIRATORY FAILURE; SPUTUM CULTURE;

AGED; ASPERGILLOSIS; BURKHOLDERIA CEPACIA; BURKHOLDERIA INFECTIONS; COMMUNITY-ACQUIRED INFECTIONS; FATAL OUTCOME; HUMANS; LUNG; MALE; PNEUMONIA, BACTERIAL;

EID: 0141625080     PISSN: 13237799     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1843.2003.00476.x     Document Type: Article

References (15)

1. Isles A, Maclusky I, Corey M et al. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J. Pediatr. 1984; 104: 206-10.
2. Speert DP, Bond M, Woodman RC, Curnutte JT. Infection with Pseudomonas cepacia in chronic granulomatous disease: role of nonoxidative killing by neutrophils in host defense. J. Infect. Dis. 1994; 170: 1524-31.
3. Wong SN, Tam AY, Yung RW, Kwan EY, Tsoi NN. Pseudomonas septicaemia in apparently healthy children. Acta Paediatr. Scand. 1991; 80: 515-20.
4. Pujol M, Corbella X, Carratala J, Gudiol F. Community-acquired bacteremic Pseudomonas cepacia pneumonia in an immunocompetent host. Clin. Infect. Dis. 1992; 15: 887-8.
5. Govan JRW, Hughes JE, Vandamme P. Burkholderia cepacia: medical, taxonomic and ecological issues. J. Med. Microbiol. 1996; 45: 395-407.
6. Govan JRW, Nelson JW. Microbiology of lung infection in cystic fibrosis. Br. Med. Bull. 1992; 48: 912-30.
7. Aronoff SC. Outer membrane permeability in Pseudomonas cepacia: diminished porin content in a β-lactam-resistant mutant and in resistant cystic fibrosis isolates. Antimicrob. Agents Chemother. 1988; 32: 1636-9.
8. Burns JL, Wadsworth CD, Barry JJ, Goodall CP. Nucleotide sequence analysis of a gene from Burkholderia (Pseudomonas) cepacia encoding an outer membrane lipoprotein involved in multiple antibiotic resistance. Antimicrob. Agents Chemother. 1996; 40: 307-13.
9. Prince A, Wood MS, Cacalano GS, Chin NX. Isolation and characterization of a penicillinase from Pseudomonas cepacia 249. Antimicrob. Agents Chemother. 1988; 32: 838-43.
10. Bonacorsi S, Fitoussi F, Lhopital S, Bingen E. Comparative in vitro activities of meropenem, imipenem, temocillin, piperacillin, and ceftazidime in combination with tobramycin, rifampin, or ciprofloxacin against Burkholderia cepacia isolates from patients with cystic fibrosis. Antimicrob. Agents Chemother. 1999; 43: 213-7.
11. Editorial. Pseudomonas cepacia - more than a harmless commensal? Lancet 1992; 339: 1385-6.
12. Gregory WJ, McNabb PC. Pseudomonas cepacia. Infect. Control. 1986; 7: 281-4.
13. Holmes A, Nolan R, Taylor R et al. An epidemic of Burkholderia cepacia transmitted between patients with and without cystic fibrosis. J. Infect. Dis. 1999; 179: 1197-205.
14. Okano M, Yamada M, Ohtsu M et al. Successful treatment with methylprednisolone pulse therapy for a life-threatening pulmonary insufficiency in a patient with chronic granulomatous disease following pulmonary invasive aspergillosis and Burkholderia capacia infection. Respiration 1999; 66: 551-4.
15. Mouy R, Fischer A, Vilmer E, Seger R, Griscelli C. Incidence, severity, and prevention of infections in chronic granulomatous disease. J. Pediatr. 1989; 114: 555-60.